Cases
Representative Matters: Represented Certified Collectibles Group, a leading global provider of authentication, grading
conservation services, in its sale to funds managed by private equity firm Blackstone (NYSE: BX)'s Tactical Opportunities business, which valued the company at more than $500 million.
Represented Allevi, Inc., a manufacturer of 3D bioprinters
bioinks trusted by leading researchers worldwide, in the $9.5 million sale of its business to 3D Systems (NYSE: DDD), a provider of 3D printing
digital manufacturing solutions.
Represented Sports Reference LLC, a sports statistics data compilation company in its purchase of certain datasets for professional baseball, football, basketball
hockey from prominent aggregators Gary Gillette, Peter Palmer
Kenneth Pullis.
Represented MLP Ventures
real estate developer J. Brian O'Neill in the closing of a $144.6 million debt
equity financing to fund MLP Ventures' purchase of the former GlaxoSmithKline Research & Development Center in Upper Merion, Pennsylvania,
to fund future operating costs, renovations,
leasing costs for prospective tenants moving into the center.
Represented DuPont (NYSE: DD), a global innovation leader with technology-based materials, in its $110 million acquisition of Evoqua's Memcor business, which includes ultrafiltration
membrane bio-filtration technologies.
Represented a foreign family office in a $5 million Series C investment in a US-based leading global provider of parcel delivery software
hardware to businesses in the U.S.
Europe.
Represented YouVisit, LLC, a company that has created virtual tours of campuses for more than 600 educational institutions, in its sale to EAB, a portfolio company of Vista Equity Partners that provides research, enterprise technology,
data-enabled services for education institutions.
Represented an affiliate of Deerfield Management Company, L.P. in a $540 million acquisition financing for the purchase of an office building at 345 Park Avenue South, New York, New York
for the redevelopment of the building as office building with lab space
financing included three mortgage loans
a mezzanine loan.
Represented New Hampshire-based Unitil Corporation (NYSE: UTL) in its sale of $30 million aggregate principal amount of 3.70% senior notes to several well-known insurance companies.
Represented Iroko Pharmaceuticals, LLC in connection with a $140 million secured loan facility with CRG, a healthcare investment fund,
the simultaneous pay-off of Iroko's loan facility with another lender.
Represented the owners of a test engineering
technical staffing services company in its sale for $39 million.
Represented the owners of a furniture retailer with approximately 40 locations in several states in its sale for $42 million.
Represented an international public energy services company
its U.S. subsidiary based in Houston in the negotiation
documentation of an amended
restated $75 million senior secured revolving credit facility. Converted the credit facility from a single-lender facility to a $75 million syndicated credit agreement, extended its maturity, added a swingline loan facility
restructured the financial covenants
certain other provisions. Certain of the borrower's international affiliates guaranteed the obligations under the facility.
Advised concerning year-end multi-country corporate restructuring for South American investors of $72 million in real estate
other assets, which were located in six jurisdictions (France, Panama, Peru, Massachusetts, Florida
Colorado)
transferred to a new South American holding company.
Represented a public company in negotiating
documenting its Fourth Amended
Restated Credit Agreement with a syndicate of lenders, increasing the capacity under the senior secured revolving credit facility from $1.3 billion to $1.8 billion. The entire amount of the facility may be used for loans
letters of credit in certain non-U.S. currencies.
Represented a specialty chemical company in closing a $175 million credit facility, comprised of revolving credit, term loan, swing line
letters of credit sub-facilities. The credit agreement contains an accordion feature affording the client the right to increase the revolving credit facility size by $50 million.
Represented Voxx International Corporation in its $20 million acquisition, through Newco, a Delaware LLC, of 54 percent of the assets of EyeLock, Inc., a Puerto Rico corporation,
EyeLock Corporation, a Delaware corporation,
a wholly-owned subsidiary of EyeLock, Inc.
Represented Quanta Services, Inc. (NYSE: PWR) in the sale of five subsidiaries comprising its fiber optic licensing operations to Houston-based Crown Castle International Corp. (NYSE: CCI) for $1 billion in cash.
Acted as sole international legal counsel to JM Financial Securities Limited
Bajaj Finance Limited on Bajaj Finance Limited's Rs. 14.0 billion (US$222 million) sale of its shares in a QIP, including a concurrent private placement to QIBs in the United States.
Served as the sole international legal counsel on Capital First Limited's recent sale of Rs. 3,000 million (US $48 million) of its shares in a qualified institutional placement (QIP), including concurrent private placements in the United States
other jurisdictions outside India. The team represented Axis Capital Limited
JM Financial Institutional Securities Limited, the Book Running Lead Managers for the offering.
Represented Aurigene Discovery Technologies Limited in its collaboration, license
option agreement with Curis, Inc. for immuno-oncology
selected precision oncology targets.
Represented a public international energy services company
its U.S. subsidiary in Houston in the negotiation
documentation of a $50 million secured revolving credit facility.
Represented TuV SuD in its strategic acquisition of RCI Consultants Inc., located in Houston, Texas.
Represented Balchem Corporation in a $450 million syndicated credit facility led by Bank of America. (Nasdaq: BCPC)
Represented a private investment company focused on casino operators
suppliers in (i) rolling up its various gaming equipment finance businesses, (ii) completing a reverse takeover of a Canadian public shell company,
(iii) completing a public offering of $10 million of common stock
$10 million of secured convertible debentures.
Represented a Chicago-based private equity fund in the sale of a Michigan headquartered benefits payments processing services company to an Ohio-based private equity firm.
Represented a manufacturer of boilers, generators
heaters in its sale to a private equity company.
Represented Iroko Pharmaceuticals, a global specialty pharmaceutical company dedicated to advancing the science of responsible pain management, in securing $75 million in debt financing to support general business operations
the commercialization of Iroko's FDA-approved ZORVOLEX (diclofenac), a drug that uses iCeutica Inc.'s proprietary SoluMatrix Fine Particle Technology to both reduce the dosage of active ingredients ingested by the patient
accelerate the dissolution of the drug in the patient.
Represented a French CAC 40 company in connection with the sale of its wind-to-energy subsidiary for $81 million.
Represented a major French CAC 40 company as lender
guarantor in connection with a $230 million project syndicated loan to a wind energy project.
Represented the lender in obtaining a $55 million secured financing, consisting of U.S.
Dutch credit facilities, provided to a global transportation company.
